Sangal Papers Limited (BOM:516096)
India · Delayed Price · Currency is INR 200.10
-10.50 (-4.99%)
At close: Aug 21, 2026
Sangal Papers Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,877 | 1,793 | 1,803 | 1,903 | 2,261 | 1,550 |
Other Revenue | 0.88 | - | - | 0.32 | 3.67 | 0.41 |
| 1,878 | 1,793 | 1,803 | 1,904 | 2,265 | 1,550 | |
Revenue Growth | 1.37% | -0.52% | -5.30% | -15.94% | 46.07% | 46.05% |
Cost of Revenue | 1,615 | 1,563 | 1,558 | 1,676 | 2,017 | 1,345 |
Gross Profit | 262.53 | 229.91 | 244.81 | 227.69 | 247.74 | 205.27 |
Selling, General & Admin | 83.52 | 82.66 | 88.28 | 88.18 | 85.34 | 79.3 |
Other Operating Expenses | 76.15 | 72.11 | 71.86 | 65.23 | 88.26 | 78.35 |
Operating Expenses | 180.86 | 174.86 | 179.33 | 170.6 | 189.5 | 171.97 |
Operating Income | 81.67 | 55.06 | 65.48 | 57.1 | 58.24 | 33.3 |
Interest Expense | -22.32 | -21.94 | -25.52 | -25.44 | -19.4 | -15.48 |
Interest & Investment Income | - | - | 0.17 | 0.26 | 0.06 | 0.01 |
Currency Exchange Gain (Loss) | - | - | 2.32 | 2.16 | 8.48 | 2.6 |
Other Non Operating Income (Expenses) | - | - | 0.36 | 0.63 | 0.52 | 0.83 |
EBT Excluding Unusual Items | 59.36 | 33.12 | 42.81 | 34.7 | 47.89 | 21.25 |
Gain (Loss) on Sale of Assets | - | - | -2.8 | -0.02 | 0.09 | -0.07 |
Pretax Income | 59.36 | 33.12 | 40.01 | 34.68 | 47.98 | 21.18 |
Income Tax Expense | 16.92 | 9.45 | 11.75 | 9.98 | 14.12 | 4.77 |
Net Income | 42.44 | 23.67 | 28.26 | 24.71 | 33.86 | 16.41 |
Net Income to Common | 42.44 | 23.67 | 28.26 | 24.71 | 33.86 | 16.41 |
Net Income Growth | 43.23% | -16.22% | 14.38% | -27.03% | 106.31% | 151.33% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Change | 0.03% | -0.00% | - | - | - | 0.02% |
EPS (Basic) | 32.46 | 18.11 | 21.62 | 18.90 | 25.90 | 12.55 |
EPS (Diluted) | 32.46 | 18.11 | 21.62 | 18.90 | 25.90 | 12.55 |
EPS Growth | 43.19% | -16.22% | 14.38% | -27.03% | 106.38% | 151.19% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -14.4 | 13.19 | 12.8 | -38.79 | 1.97 |
Free Cash Flow Per Share | - | -11.02 | 10.09 | 9.79 | -29.67 | 1.51 |
Gross Margin | 13.98% | 12.82% | 13.58% | 11.96% | 10.94% | 13.24% |
Operating Margin | 4.35% | 3.07% | 3.63% | 3.00% | 2.57% | 2.15% |
Profit Margin | 2.26% | 1.32% | 1.57% | 1.30% | 1.49% | 1.06% |
Free Cash Flow Margin | - | -0.80% | 0.73% | 0.67% | -1.71% | 0.13% |
EBITDA | 101.99 | 75.15 | 84.67 | 74.28 | 74.14 | 47.62 |
EBITDA Margin | 5.43% | 4.19% | 4.70% | 3.90% | 3.27% | 3.07% |
D&A For EBITDA | 20.31 | 20.09 | 19.19 | 17.19 | 15.9 | 14.33 |
EBIT | 81.67 | 55.06 | 65.48 | 57.1 | 58.24 | 33.3 |
EBIT Margin | 4.35% | 3.07% | 3.63% | 3.00% | 2.57% | 2.15% |
Effective Tax Rate | 28.51% | 28.52% | 29.37% | 28.76% | 29.43% | 22.52% |
Revenue as Reported | 1,886 | 1,802 | 1,809 | 1,913 | 2,281 | 1,556 |
Advertising Expenses | - | - | 0.39 | 2.39 | 1.12 | 0.47 |